• Heme oxygenase-1 regulates the progression of K/BxN serum transfer arthritis.
  Brines R, Maicas N, Ferrándiz ML, Loboda A, Jozkowicz A, Dulak J, Alcaraz MJ.
  PLoS One. 2012; 7: e52435.
  
• Angiogenesis, stem cells, eNOS and inflammation--the many faces of vascular biology.
  Dulak J, Guzik TJ.
  Thromb Haemost. 2012; 108: 801-803.
  
• Exercise training in intermittent claudication: effects on antioxidant genes, inflammatory mediators and proangiogenic progenitor cells.
  Nowak WN, Mika P, Nowobilski R, Kusinska K, Bukowska-Strakova K, Nizankowski R, Józkowicz A, Szczeklik A, Dulak J.
  Thromb Haemost. 2012; 108: 824-831.
  
• Vessel wall - where coagulation meets cell biology and immunology.
  Guzik TJ, Dulak J.
  Thromb Haemost. 2012;108: 416-8.
  
• Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury.
  Wojakowski W, Tendera M, Cybulski W, Zuba-Surma EK, Szade K, Florczyk U, Kozakowska M, Szymula A, Krzych L, Paslawska U, Pasławski R, Milewski K, Buszman P, Nabiałek E, Kuczmik W, Janiszewski A, Dzięgiel P, Buszman PE, Józkowicz A, Dulak J.
  Thromb Haemost. 2012;108: 464-75.
  
• Current prospects in vascular biology and medicine.
  Dulak J, Jozkowicz A.
  Vascul Pharmacol. 2012; 56: 183-4.
  
• HIF-1 versus HIF-2--is one more important than the other?
  Loboda A, Jozkowicz A, Dulak J.
  Vascul Pharmacol. 2012; 56: 245-51.
  
• Haem oxygenase-1: non-canonical roles in physiology and pathology.
  Grochot-Przeczek A, Dulak J, Jozkowicz A.
  Clin Sci (Lond). 2012; 122: 93-103.
  
• Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs.
  Kozakowska M, Ciesla M, Stefanska A, Skrzypek K, Was H, Jazwa A, Grochot-Przeczek A, Kotlinowski J, Szymula A, Bartelik A, Mazan M, Yagensky O, Florczyk U, Lemke K, Zebzda A, Dyduch G, Nowak W, Szade K, Stepniewski J, Majka M, Derlacz R, Loboda A, Dulak J, Jozkowicz A.
  Antioxid Redox Signal. 2012;16: 113-27.
  

« 2011 | 2013 »